What is the 13F Pro Quality Score for NUWE?

13F Pro ranks Nuwellis, Inc. (NUWE) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View NUWE's current score at https://13fpro.ai/research/NUWE (free sign-up required for the full ranking).

Where does 13F Pro source NUWE data?

All Nuwellis, Inc. fundamentals and ownership data come directly from SEC EDGAR. Nuwellis, Inc. files with the SEC under CIK 1506492. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is NUWE in?

Nuwellis, Inc. (NUWE) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is NUWE research updated on 13F Pro?

NUWE's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Nuwellis, Inc.(NUWE)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 1506492 NUWE stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $8.9M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

NUWE Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Nuwellis, Inc. (NUWE), a Healthcare sector company. NUWE is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $8.9m in revenue. Based on the latest XBRL financial filings (Q1 2026), Nuwellis, Inc. reports quarterly revenue of $2.4M, net income of $-4.5M, free cash flow of $-3.1M. Top institutional holders of NUWE by reported 13-F value include ARMISTICE CAPITAL,, GEODE CAPITAL MANAGEMENT,, Tower Research Capital (TRC), based on the most recent SEC filings. NUWE trades on the Nasdaq exchange and files with the SEC under CIK 1506492. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NUWE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Nuwellis, Inc. directly from SEC EDGAR.

Revenue

Q1 2026

$2.4M

Net Income

Q1 2026

$-4.5M

Free Cash Flow

Q1 2026

$-3.1M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-5.4% YoY

$8.3MFY 2025

FY21 $7.9MFY22 $8.5MFY24 $8.7MFY25 $8.3M

Net Income

-56.9% YoY

$-17.5MFY 2025

FY21 $-19.6MFY22 $-14.5MFY24 $-11.2MFY25 $-17.5M

Operating Income

-1.1% YoY

$-11.1MFY 2025

FY21 $-19.5MFY22 $-17.2MFY24 $-11.0MFY25 $-11.1M

EPS (Diluted)

+92.8% YoY

$-25.39FY 2025

FY21 $-285.36FY22 $-83.55FY24 $-353.30FY25 $-25.39

Total Assets

-38.0% YoY

$6.1MFY 2025

FY21 $30.4MFY22 $24.7MFY24 $9.9MFY25 $6.1M

Op. Cash Flow

-12.7% YoY

$-10.8MFY 2025

FY21 $-17.8MFY22 $-15.1MFY24 $-9.6MFY25 $-10.8M

Metric	FY 2025	FY 2024	FY 2022	FY 2021	FY 2020	FY 2018
Revenue	$8.3M -5.4%	$8.7M +2.3%	$8.5M +7.9%	$7.9M +6.5%	$7.4M +48.9%	$5.0M
Net Income	$-17.5M -56.9%	$-11.2M +23.1%	$-14.5M +25.7%	$-19.6M -23.5%	$-15.8M +7.0%	$-17.0M
Operating Income	$-11.1M -1.1%	$-11.0M +36.0%	$-17.2M +12.1%	$-19.5M -14.7%	$-17.0M +0.0%	$-17.0M
EPS (Diluted)	$-25.39 +92.8%	$-353.30 -322.9%	$-83.55 +70.7%	$-285.36 -2574.4%	$-10.67	—
Total Assets	$6.1M -38.0%	$9.9M -60.0%	$24.7M -18.9%	$30.4M +52.0%	$20.0M +128.0%	$8.8M
Operating Cash Flow	$-10.8M -12.7%	$-9.6M +36.7%	$-15.1M +15.1%	$-17.8M -7.7%	$-16.6M -13.8%	$-14.6M

AI Insight: NUWE Financial Trends

Revenue remains stalled at $2M quarterly while operating losses have worsened; company burns cash consistently with no path to profitability visible.

• Revenue flat at $2M for eight consecutive quarters (Q2 2024–Q1 2026); zero revenue growth.

• Operating income deteriorated to –$5M in Q1 2026 from –$2M in Q4 2024; margin compression ongoing.

• Operating cash flow consistently negative (–$2M to –$3M per quarter); cumulative burn of $21M over eight quarters.

⚠ Net income swung to –$5M loss in Q1 2026, worst result since Q2 2024; deteriorating operational efficiency.

⚠ Equity oscillated between –$9M (Q2 2025) and +$7M (Q4 2024); balance sheet unstable and near insolvency risk.

AI Insight: NUWE Ratio Trends

Nuwellis remains unprofitable across all metrics; operating margin deteriorated to -190.1% in Q1 2026, the worst reading in the dataset.

• Operating margin worsened from -100.8% in Q4 2025 to -190.1% in Q1 2026, a 89.3pp decline. Net profit margin fell to -189.0%.

• Q3 2025 showed brief profitability: NPM 21.1%, ROE 47.9%, ROA 23.4%. Reversed sharply in subsequent quarters.

⚠ Q1 2026 margins hit multi-quarter lows despite no leverage data available. Sustainability of operations at current burn rate unclear.

⚠ Q3 2025 profitability spike followed by deeper losses suggests potential one-time benefit or unsustainable operational pattern.

Get alerted when NUWE's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Nuwellis, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of NUWE

ARMISTICE CAPITAL, LLC
$248.0K236,200 sh
GEODE CAPITAL MANAGEMENT, LLC
$46.4K44,176 sh
Tower Research Capital LLC (TRC)
$5.4K5,189 sh
CITIGROUP INC
$5.4K5,126 sh
SBI Securities Co., Ltd.
$66.0063 sh
UBS Group AG
$48.0046 sh
Caitong International Asset Management Co., Ltd
$4.004 sh
Ankerstar Wealth, LLC
$1.001 sh

Fund	Value	Shares
ARMISTICE CAPITAL, LLC	$248.0K	236,200
GEODE CAPITAL MANAGEMENT, LLC	$46.4K	44,176
Tower Research Capital LLC (TRC)	$5.4K	5,189
CITIGROUP INC	$5.4K	5,126
SBI Securities Co., Ltd.	$66.00	63
UBS Group AG	$48.00	46
Caitong International Asset Management Co., Ltd	$4.00	4
Ankerstar Wealth, LLC	$1.00	1

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put NUWE on your watchlist

Track score changes the day Nuwellis, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is NUWE a good stock to buy?

13F Pro's AI-powered analysis of Nuwellis, Inc. (NUWE) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NUWE are available on the NUWE stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own NUWE?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NUWE. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Nuwellis, Inc.'s investment landscape.